Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia, Inc. (NYSE: PHR) plans to release its fiscal fourth quarter and full year 2021 financial results on March 30, 2021, after market close. A conference call to discuss these results will be held on March 31, 2021, at 8:30 a.m. ET. Interested parties can join the call by dialing (866) 211-4557 or (647) 689-6750 for international calls, using conference code 3387628. Phreesia offers a robust SaaS platform to streamline patient intake processes, improving healthcare engagement and operational efficiency.
Phreesia has been awarded the 2021 Best in KLAS for Patient Intake Management by KLAS, an insights firm. The award recognizes top-performing healthcare IT companies based on feedback from healthcare organizations. Phreesia achieved a score of 91.3, reflecting provider evaluations across various customer experience areas. This marks the third consecutive year Phreesia has received top honors for this category, previously winning in 2020 and being named Category Leader in 2019. CEO Chaim Indig expressed gratitude to clients and team members for their support.
Summary not available.
Phreesia, a leader in patient intake solutions, has received certification from the Alliance for Audited Media (AAM) for its PatientConnect platform. This certification validates that the platform’s advertising measurement systems adhere to high industry standards. Phreesia’s commitment to continuous auditing ensures accuracy and reliability, maintaining industry-level performance. AAM’s ongoing audits include evaluating targeting criteria and patient authorization processes. The collaboration emphasizes Phreesia’s transparency and data integrity in the healthcare advertising sector.
Phreesia has joined the Zoom App Marketplace, enhancing its Intake for Telehealth solution. This integration offers automated patient intake processes for telehealth visits, allowing healthcare providers to generate unique meeting links and collect essential patient information efficiently. Over 100 healthcare organizations, including a 17-provider gastroenterology group, are already benefiting from this partnership. The streamlined registration improves the overall patient experience during virtual consultations.
Office Practicum (OP) has partnered with Phreesia to integrate their pediatric-specific EHR and patient intake management systems. This collaboration aims to enhance operational efficiency for pediatric practices by enabling seamless data capture during patient intake, improving the overall healthcare experience for families. OP's SVP of Product emphasized the accessibility of high-quality tools for practices, while Phreesia's CEO highlighted their shared mission of supporting pediatric care. The integration promises to streamline workflows, allowing for a convenient patient check-in process.
Phreesia, Inc. (NYSE: PHR) announced the retirement of CFO Tom Altier, effective April 2021, with Randy Rasmussen set to take over as CFO from May 1, 2021. Altier, who has been with Phreesia since 2012, will remain in an advisory role post-retirement. CEO Chaim Indig praised Altier's leadership in the company's successful transition to public status. Rasmussen, who joined as Chief Accounting Officer in 2019, brings over 25 years of finance experience to his new position. Phreesia provides healthcare organizations with innovative patient intake management solutions.
Phreesia, Inc. (NYSE: PHR) reported Q3 fiscal 2021 results with revenue of $38.5 million, a 17% increase year-over-year. The average number of provider clients rose to 1,737, marking a 10% growth. Average revenue per provider client reached $17,490, a 5% increase. Adjusted EBITDA was $1.2 million, down from $3.0 million in the prior year. Cash at the end of the quarter stood at $254.1 million, boosted by a follow-on stock offering. However, the company anticipates continued uncertainty due to COVID-19's impact on client operations and revenue.
Phreesia, Inc. (NYSE: PHR) will announce its fiscal Q3 2021 financial results on December 8, 2020, after market close. A conference call and webcast to discuss these results is scheduled for December 9, 2020, at 8:30 a.m. ET. The company provides healthcare organizations with innovative SaaS solutions to optimize patient intake processes, enhancing both patient engagement and clinical efficiency. Investors can participate in the call by dialing (866) 211-4557 or (647) 689-6750 internationally.
Summary not available.